Moderna Says Their Bivalent Vaccine Works Against Omicron
(MedPage Today) -- Moderna's bivalent COVID-19 booster candidate was safe and well tolerated, with a better immune response against Omicron versus a booster dose of the company's approved vaccine (Spikevax), the manufacturer said on Wednesday...
Read more »